Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07536477 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Third Military Medical University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Enrollment target: 200 to 208
    • Secondary endpoints revised (4)
    v3
  2. Recruitment opened
    • Start date changed from estimate of Apr 22, 2026 to Apr 25, 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).
Trial Details
NCT Number NCT07536477
Lead Sponsor Third Military Medical University
Conditions
(from sponsor)		 High-altitude Pulmonary Edema
Related terms Altitude Sickness
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov